Breaking News Instant updates and real-time market news.

NVIV

InVivo Therapeutics

$4.30

0.1 (2.38%)

08:04
10/19/16
10/19
08:04
10/19/16
08:04

InVivoa announces Foothills Medical Centre as new site for INSPIRE study

InVivo Therapeutics Holdings announced that the Foothills Medical Centre in Calgary, Alberta has been added as a Canadian clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. The Foothills Medical Centre is the largest hospital in Alberta and is one of the most recognized medical facilities in Canada, providing advanced healthcare services to over two million people from Calgary and southern Alberta, the northwestern United States, southeastern British Columbia, and southern Saskatchewan.

NVIV InVivo Therapeutics
$4.30

0.1 (2.38%)

07/07/16
RAJA
07/07/16
INITIATION
Target $13
RAJA
Strong Buy
Invivo Therapeutics initiated with a Strong Buy at Raymond James
Raymond James analyst Reni Benjamin initiated Invivo Therapeutics with a Strong Buy and $13 price target saying it is a leading player in the spinal cord injury space.
07/07/16
07/07/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aflac (AFL) initiated with a Sell at Evercore ISI with analyst Thomas Gallagher saying the market is overly focused on the benefit of a stronger yen and not enough on the negative impact created by negative government yields in Japan. 2. Shake Shack (SHAK) initiated with an Underperform at Wedbush with analyst Nick Setyan saying he expects its valuation to continue to contract, given that the stock's current valuation implies a much larger sales opportunity than management's guidance. 3. Invivo Therapeutics (NVIV) initiated with a Strong Buy at Raymond James. 4. CBS (CBS) and Time Warner (TWX) initiated with a Buy at Brean Capital. 5. Disney (DIS), Viacom (VIA), and 21st Century Fox (FOX) initiated with a Hold at Brean Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/16
LTCO
07/21/16
INITIATION
Target $23.25
LTCO
Buy
Invivo Therapeutics initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Jeffrey Cohen started Invivo Therapeutics with a Buy rating and $23.25 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.